FormWeb • Hazard.Drug Handling(USP 800)

IHS FormWeb

Approved Formulary

Search by class Show Therapeutic Classes

Staff Telephone Numbers

Add Formweb to your mobile device

Android iOS

Hazard.Drug Handling(USP 800)

Please review each of these drugs carefully.

abacavir	USP<800> Hazardous Drug / Assessment of Risk
abiraterone	USP<800> Hazardous Drug
acitretin	USP<800> Hazardous Drug
ado-trastuzumab emtansine	USP<800> Hazardous Drug
afatinib	USP<800> Hazardous Drug
alefacept	USP<800> Hazardous Drug
alitretinoin topical	USP<800> Hazardous Drug
altretamine	USP<800> Hazardous Drug
ambrisentan	USP<800> Hazardous Drug
amsacrine	USP<800> Hazardous Drug
anastrozole	USP<800> Hazardous Drug / Assessment of Risk
apomorphine	USP<800> Hazardous Drug
arsenic trioxide	USP<800> Hazardous Drug
axitinib	USP<800> Hazardous Drug
azaCITIDine	USP<800> Hazardous Drug
azaTHIOprine IV	USP<800> Hazardous Drug
azaTHIOprine PO	USP<800> Hazardous Drug
belantamab mafodotin	USP<800> Hazardous Drug
belinostat	USP<800> Hazardous Drug
bendamustine	USP<800> Hazardous Drug
bexarotene	USP<800> Hazardous Drug
bicalutamide	USP<800> Hazardous Drug / Assessment of Risk
bleomycin	USP<800> Hazardous Drug
blinatumomab	USP<800> Hazardous Drug
bortezomib	USP<800> Hazardous Drug
bosentan	USP<800> Hazardous Drug
bosutinib	USP<800> Hazardous Drug
BRENtuximab vedotin	USP<800> Hazardous Drug
busulfan	USP<800> Hazardous Drug
cabazitaxel	USP<800> Hazardous Drug
cabergoline	USP<800> Hazardous Drug
cabozantinib	USP<800> Hazardous Drug
capecitabine	USP<800> Hazardous Drug
carBAMazepine	USP<800> Hazardous Drug / Assessment of Risk
CARBOplatin	USP<800> Hazardous Drug
carfilzomib	USP<800> Hazardous Drug
carmustine	USP<800> Hazardous Drug
ceritinib	USP<800> Hazardous Drug
cetrorelix	USP<800> Hazardous Drug
chlorambucil	USP<800> Hazardous Drug
chloramphenicol	USP<800> Hazardous Drug
cidofovir	USP<800> Hazardous Drug / Assessment of Risk
CISplatin	USP<800> Hazardous Drug
cladribine	USP<800> Hazardous Drug
cloBAZam	USP<800> Hazardous Drug
clofarabine	USP<800> Hazardous Drug
clomiPHENE	USP<800> Hazardous Drug
clonazePAM	USP<800> Hazardous Drug / Assessment of Risk
cobimetinib	USP<800> Hazardous Drug
colchicine	USP<800> Hazardous Drug / Assessment of Risk
conjugated estrogens IV	USP<800> Hazardous Drug / Assessment of Risk
conjugated estrogens PO	USP<800> Hazardous Drug / Assessment of Risk
crizotinib	USP<800> Hazardous Drug
cyclophosphamide IV	USP<800> Hazardous Drug
cyclophosphamide PO	USP<800> Hazardous Drug / Assessment of Risk
cycloSPORINE IV	USP<800> Hazardous Drug
cycloSPORINE PO	USP<800> Hazardous Drug / Assessment of Risk
cytarabine	USP<800> Hazardous Drug
dabrafenib	USP<800> Hazardous Drug
dacarbazine	USP<800> Hazardous Drug
DACTINomycin	USP<800> Hazardous Drug
dasatinib	USP<800> Hazardous Drug
DAUNOrubicin	USP<800> Hazardous Drug
decitabine	USP<800> Hazardous Drug
deferiprone	USP<800> Hazardous Drug
degarelix	USP<800> Hazardous Drug
demo	USP<800> Hazardous Drug / Assessment of Risk
dexrazoxane	USP<800> Hazardous Drug
diethylstilbestrol	USP<800> Hazardous Drug
dihydroergotamine	USP<800> Hazardous Drug
dinoprostone topical	USP<800> Hazardous Drug / Assessment of Risk
DOCEtaxel	USP<800> Hazardous Drug
DOXOrubicin	USP<800> Hazardous Drug
DOXOrubicin liposomal	USP<800> Hazardous Drug
dronedarone	USP<800> Hazardous Drug / Assessment of Risk
dutasteride	USP<800> Hazardous Drug / Assessment of Risk
enfortumab vedotin	USP<800> Hazardous Drug
entecavir	USP<800> Hazardous Drug
enzalutamide	USP<800> Hazardous Drug
epiRUBicin	USP<800> Hazardous Drug
eriBULin	USP<800> Hazardous Drug
erlotinib	USP<800> Hazardous Drug / Assessment of Risk
eslicarbazepine	USP<800> Hazardous Drug
esterified estrogens	USP<800> Hazardous Drug / Assessment of Risk
esterified estrogens-methylTESTOSTERone	USP<800> Hazardous Drug / Assessment of Risk
estradiol	USP<800> Hazardous Drug / Assessment of Risk
estradiol IM	USP<800> Hazardous Drug
estradiol patch	USP<800> Hazardous Drug / Assessment of Risk
estradiol vaginal	USP<800> Hazardous Drug / Assessment of Risk
estramustine	USP<800> Hazardous Drug
estropipate	USP<800> Hazardous Drug
ethinyl estradiol-norethindrone	USP<800> Hazardous Drug / Assessment of Risk
etoposide	USP<800> Hazardous Drug
everolimus	USP<800> Hazardous Drug
exemestane	USP<800> Hazardous Drug / Assessment of Risk
exenatide	USP<800> Hazardous Drug
fam-trastuzumab deruxtecan	USP<800> Hazardous Drug
finasteride	USP<800> Hazardous Drug / Assessment of Risk
fingolimod	USP<800>
floxuridine	USP<800> Hazardous Drug
fluconazole IV	USP<800> Hazardous Drug / Assessment of Risk
fluconazole PO	USP<800> Hazardous Drug / Assessment of Risk
fludarabine	USP<800> Hazardous Drug
fluorouracil	USP<800> Hazardous Drug
fluoxymesterone	USP<800> Hazardous Drug
flutamide	USP<800> Hazardous Drug
fosphenytoin	USP<800> Hazardous Drug
fulvestrant	USP<800> Hazardous Drug
ganciclovir IV	USP<800> Hazardous Drug / Assessment of Risk
ganciclovir ophthalmic	USP<800> Hazardous Drug / Assessment of Risk
ganirelix	USP<800> Hazardous Drug
gemcitabine	USP<800> Hazardous Drug
gemtuzumab ozogamicin	USP<800> Hazardous Drug
gonadotropin, chorionic (HCG)	USP<800> Hazardous Drug
goserelin	USP<800> Hazardous Drug
histrelin	USP<800> Hazardous Drug
hydroxyurea	USP<800> Hazardous Drug / Assessment of Risk
icatibant	USP<800> Hazardous Drug
IDArubicin	USP<800> Hazardous Drug
ifosfamide	USP<800> Hazardous Drug
imatinib	USP<800> Hazardous Drug
inotuzumab ozogamicin	USP<800> Hazardous Drug
irinotecan	USP<800> Hazardous Drug
ISOtretinoin	USP<800> Hazardous Drug
ivabradine	USP<800> Hazardous Drug
ixabepilone	USP<800> Hazardous Drug
ixazomib	USP<800> Hazardous Drug
lamiVUDine-zidovudine	USP<800> Hazardous Drug
leflunomide	USP<800> Hazardous Drug / Assessment of Risk
lenalidomide	USP<800> Hazardous Drug
lenvatinib	USP<800> Hazardous Drug
letrozole	USP<800> Hazardous Drug / Assessment of Risk
leuprolide	USP<800> Hazardous Drug
levonorgestrel	USP<800> Hazardous Drug
lomitapide	USP<800> Hazardous Drug
lomustine	USP<800> Hazardous Drug
loncastuximab tesirine	USP<800> Hazardous Drug
lurbinectedin	USP<800> Hazardous Drug
macitentan	USP<800> Hazardous Drug
mechlorethamine	USP<800> Hazardous Drug
medroxyPROGESTERone IM	USP<800> Hazardous Drug / Assessment of Risk
medroxyPROGESTERone PO	USP<800> Hazardous Drug / Assessment of Risk
megestrol	USP<800> Hazardous Drug / Assessment of Risk
melphalan flufenamide	USP<800> Hazardous Drug
melphalan PO	USP<800> Hazardous Drug
menotropins	USP<800> Hazardous Drug
mercaptopurine	USP<800> Hazardous Drug / Assessment of Risk
methIMAzole	USP<800> Hazardous Drug / Assessment of Risk
methotrexate IV	USP<800> Hazardous Drug
methotrexate PO	USP<800> Hazardous Drug / Assessment of Risk
methylergonovine IV/IM	USP<800> Hazardous Drug / Assessment of Risk
methylergonovine PO	USP<800> Hazardous Drug / Assessment of Risk
methylTESTOSTERone	USP<800> Hazardous Drug
miFEPRIStone	USP<800> Hazardous Drug
miltefosine	USP<800> Hazardous Drug
mipomersen	USP<800> Hazardous Drug
mirvetuximab soravtansine	USP<800> Hazardous Drug
miSOPROStol	USP<800> Hazardous Drug / Assessment of Risk
mitoMYcin	USP<800> Hazardous Drug
mitoMYcin ophthalmic	USP<800> Hazardous Drug / Assessment of Risk
mitotane	USP<800> Hazardous Drug
mitoXANTRONE	USP<800> Hazardous Drug
mycophenolate mofetil IV	USP<800> Hazardous Drug
mycophenolate mofetil PO (Capsule)	USP<800> Hazardous Drug / Assessment of Risk
mycophenolic acid	USP<800> Hazardous Drug / Assessment of Risk
nafarelin	USP<800> Hazardous Drug
nelarabine	USP<800> Hazardous Drug
nevirapine	USP<800> Hazardous Drug
nilotinib	USP<800> Hazardous Drug
norethindrone	USP<800> Hazardous Drug
olaparib	USP<800> Hazardous Drug
omacetaxine	USP<800> Hazardous Drug
ospemifene	USP<800> Hazardous Drug
OXALIplatin	USP<800> Hazardous Drug
OXcarbazepine	USP<800> Hazardous Drug / Assessment of Risk
oxytocin	USP<800> Hazardous Drug / Assessment of Risk
PACLitaxel	USP<800> Hazardous Drug
PACLitaxel protein-bound particles	USP<800> Hazardous Drug
palifermin	USP<800> Hazardous Drug
pamidronate	USP<800> Hazardous Drug / Assessment of Risk
panobinostat	USP<800> Hazardous Drug
PARoxetine	USP<800> Hazardous Drug / Assessment of Risk
pasireotide	USP<800> Hazardous Drug
PAZOPanib	USP<800> Hazardous Drug
peginesatide	USP<800> Hazardous Drug
PEMEtrexed	USP<800> Hazardous Drug
pentetate calcium trisodium	USP<800> Hazardous Drug
pentostatin	USP<800> Hazardous Drug
phenoxybenzamine	USP<800> Hazardous Drug
phenytoin IV	USP<800> Hazardous Drug / Assessment of Risk
phenytoin PO	USP<800> Hazardous Drug / Assessment of Risk
pipobroman	USP<800> Hazardous Drug
plerixafor	USP<800> Hazardous Drug
polatuzumab vedotin	USP<800> Hazardous Drug
pomalidomide	USP<800> Hazardous Drug
PONATinib	USP<800> Hazardous Drug
PRALAtrexate	USP<800> Hazardous Drug
procarbazine	USP<800> Hazardous Drug
progesterone	USP<800> Hazardous Drug / Assessment of Risk
propylthiouracil	USP<800> Hazardous Drug / Assessment of Risk
raloxifene	USP<800> Hazardous Drug / Assessment of Risk
rasagiline	USP<800> Hazardous Drug
regorafenib	USP<800> Hazardous Drug
ribavirin	USP<800> Hazardous Drug
riociguat	USP<800> Hazardous Drug
romiDEPsin	USP<800> Hazardous Drug
sacituzumab govitecan	USP<800> Hazardous Drug
sirolimus	USP<800> Hazardous Drug
sonidegib	USP<800> Hazardous Drug
SORAfenib	USP<800> Hazardous Drug
spironolactone	USP<800> Hazardous Drug / Assessment of Risk
streptozocin	USP<800> Hazardous Drug
SUNItinib	USP<800> Hazardous Drug
tacrolimus	USP<800> Hazardous Drug / Assessment of Risk
tamoxifen	USP<800> Hazardous Drug / Assessment of Risk
temazepam	USP<800> Hazardous Drug / Assessment of Risk
temozolomide	USP<800> Hazardous Drug
temsirolimus	USP<800> Hazardous Drug
teniposide	USP<800> Hazardous Drug
teriflunomide	USP<800> Hazardous Drug
testosterone IM	USP<800> Hazardous Drug / Assessment of Risk
testosterone topical	USP<800> Hazardous Drug
thalidomide	USP<800> Hazardous Drug
thioguanine	USP<800> Hazardous Drug
thiotepa	USP<800> Hazardous Drug
tipiracil-trifluridine	USP<800> Hazardous Drug
tisotumab vedotin	USP<800> Hazardous Drug
tofacitinib	USP<800> Hazardous Drug
topiramate	USP<800> Hazardous Drug / Assessment of Risk
topotecan	USP<800> Hazardous Drug
toremifene	USP<800> Hazardous Drug
trabectedin	USP<800> Hazardous Drug
trametinib	USP<800> Hazardous Drug
tretinoin topical	USP<800> Hazardous Drug
triptorelin	USP<800> Hazardous Drug
ulipristal	USP<800> Hazardous Drug
uracil mustard	USP<800> Hazardous Drug
urofollitropin	USP<800> Hazardous Drug
valGANciclovir	USP<800> Hazardous Drug / Assessment of Risk
valproic acid IV	USP<800> Hazardous Drug / Assessment of Risk
valproic acid PO	USP<800> Hazardous Drug / Assessment of Risk
valrubicin	USP<800> Hazardous Drug
vandetanib	USP<800> Hazardous Drug
vemurafenib	USP<800> Hazardous Drug
vigabatrin	USP<800> Hazardous Drug
vinBLAStine	USP<800> Hazardous Drug
vinCRIStine	USP<800> Hazardous Drug
vinORELBine	USP<800> Hazardous Drug
vismodegib	USP<800> Hazardous Drug
voriconazole IV	USP<800> Hazardous Drug / Assessment of Risk
voriconazole PO	USP<800> Hazardous Drug / Assessment of Risk
vorinostat	USP<800> Hazardous Drug
warfarin	USP<800> Hazardous Drug / Assessment of Risk
zidovudine	USP<800> Hazardous Drug
ziprasidone IM	USP<800> Hazardous Drug / Assessment of Risk
ziprasidone PO	USP<800> Hazardous Drug / Assessment of Risk
ziv-aflibercept	USP<800> Hazardous Drug
zoledronic acid	USP<800> Hazardous Drug / Assessment of Risk
zonisamide	USP<800> Hazardous Drug / Assessment of Risk

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.